Trial Profile
Pivotal phase III trial of telapristone in patients with endometriosis
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2009
Price :
$35
*
At a glance
- Drugs Telapristone (Primary)
- Indications Endometriosis
- Focus Registrational; Therapeutic Use
- Sponsors Repros Therapeutics
- 03 Aug 2009 Status changed from planning to suspended, according to a Repros Therapeutics media release.
- 02 Jul 2009 New trial record.